These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 16478772

  • 1. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
    Lautamäki R, Borra R, Iozzo P, Komu M, Lehtimäki T, Salmi M, Jalkanen S, Airaksinen KE, Knuuti J, Parkkola R, Nuutila P.
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E282-90. PubMed ID: 16478772
    [Abstract] [Full Text] [Related]

  • 2. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
    Rijzewijk LJ, Jonker JT, van der Meer RW, Lubberink M, de Jong HW, Romijn JA, Bax JJ, de Roos A, Heine RJ, Twisk JW, Windhorst AD, Lammertsma AA, Smit JW, Diamant M, Lamb HJ.
    J Am Coll Cardiol; 2010 Jul 13; 56(3):225-33. PubMed ID: 20620743
    [Abstract] [Full Text] [Related]

  • 3. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.
    Gastroenterology; 2008 Jul 13; 135(1):122-30. PubMed ID: 18474251
    [Abstract] [Full Text] [Related]

  • 4. [Relationship of liver fat content to insulin resistance and metabolic syndrome].
    Yan HM, Gao X, Liu M, Gu Q, Zhang B, Li X.
    Zhonghua Yi Xue Za Zhi; 2008 May 13; 88(18):1255-8. PubMed ID: 18844098
    [Abstract] [Full Text] [Related]

  • 5. Effect of liver fat on insulin clearance.
    Kotronen A, Vehkavaara S, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H.
    Am J Physiol Endocrinol Metab; 2007 Dec 13; 293(6):E1709-15. PubMed ID: 17895288
    [Abstract] [Full Text] [Related]

  • 6. Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease.
    Winkelmann BR, Boehm BO, Nauck M, Kleist P, März W, Verho NK, Ranjith N, Kneissl G.
    Curr Med Res Opin; 2001 Dec 13; 17(2):132-41. PubMed ID: 11759183
    [Abstract] [Full Text] [Related]

  • 7. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
    Rijkelijkhuizen JM, Doesburg T, Girman CJ, Mari A, Rhodes T, Gastaldelli A, Nijpels G, Dekker JM.
    Metabolism; 2009 Feb 13; 58(2):196-203. PubMed ID: 19154952
    [Abstract] [Full Text] [Related]

  • 8. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.
    Paternostro G, Camici PG, Lammerstma AA, Marinho N, Baliga RR, Kooner JS, Radda GK, Ferrannini E.
    J Clin Invest; 1996 Nov 01; 98(9):2094-9. PubMed ID: 8903329
    [Abstract] [Full Text] [Related]

  • 9. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ, Lip GY, Patel JV, MacFadyen RJ, Varma C.
    J Intern Med; 2009 Jun 01; 265(6):689-97. PubMed ID: 19226374
    [Abstract] [Full Text] [Related]

  • 10. Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis.
    Chalasani N, Deeg MA, Persohn S, Crabb DW.
    Am J Gastroenterol; 2003 Aug 01; 98(8):1849-55. PubMed ID: 12907343
    [Abstract] [Full Text] [Related]

  • 11. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects.
    Kotronen A, Juurinen L, Hakkarainen A, Westerbacka J, Cornér A, Bergholm R, Yki-Järvinen H.
    Diabetes Care; 2008 Jan 01; 31(1):165-9. PubMed ID: 17934148
    [Abstract] [Full Text] [Related]

  • 12. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.
    Perseghin G, Bonfanti R, Magni S, Lattuada G, De Cobelli F, Canu T, Esposito A, Scifo P, Ntali G, Costantino F, Bosio L, Ragogna F, Del Maschio A, Chiumello G, Luzi L.
    Am J Physiol Endocrinol Metab; 2006 Oct 01; 291(4):E697-703. PubMed ID: 16684857
    [Abstract] [Full Text] [Related]

  • 13. Do high ferritin levels confer lower cardiovascular risk in men with Type 2 diabetes?
    Hermans MP, Ahn SA, Amoussou-Guenou KD, Balde NM, Rousseau MF.
    Diabet Med; 2010 Apr 01; 27(4):417-22. PubMed ID: 20536513
    [Abstract] [Full Text] [Related]

  • 14. Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations.
    Ardigò D, Numeroso F, Valtueña S, Franzini L, Piatti PM, Monti L, Delsignore R, Reaven GM, Zavaroni I.
    Metabolism; 2005 Dec 01; 54(12):1566-70. PubMed ID: 16311087
    [Abstract] [Full Text] [Related]

  • 15. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.
    Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ.
    J Am Coll Cardiol; 2008 Nov 25; 52(22):1793-9. PubMed ID: 19022158
    [Abstract] [Full Text] [Related]

  • 16. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA.
    Gastroenterology; 2007 Aug 25; 133(2):496-506. PubMed ID: 17681171
    [Abstract] [Full Text] [Related]

  • 17. Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance.
    Perseghin G, Caumo A, Lattuada G, De Cobelli F, Ntali G, Esposito A, Belloni E, Canu T, Ragogna F, Scifo P, Del Maschio A, Luzi L.
    Diabet Med; 2009 Sep 25; 26(9):847-54. PubMed ID: 19719704
    [Abstract] [Full Text] [Related]

  • 18. The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2.
    Endler G, Exner M, Raith M, Marculescu R, Mannhalter C, Endler L, Wojta J, Huber K, Wagner OF.
    Thromb Res; 2003 Sep 25; 112(1-2):47-50. PubMed ID: 15013273
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.